Main > RHEUMATOLOGY>RHEUMATOID ARTHRITIS > Treatment > p38 MAP Kinase Inhibitor Program > Compound (Co.: USA. Arr.)

---

Compound (Co.: USA. Arr.)'s subsections
Development By:
Indication:
Market: Oral Active Etanercept
Results:
Status: PreClinical (07.03)
Target Family: Kinases

Compound (Co.: USA. Arr.)'s products
This section has no products